Interleukin-2 and Killer Cells in Cancer
Regular price
€210.80
14 days return policy
Shipping & Delivery
A. B. DeLeo
A. Lindemann
A01=Eva Lotzova
activation
activity
adoptive cell transfer
Adoptive Transfer
advanced cancer immunotherapy strategies
Ait
Alfred E. Chang
Anna T. Brini
Annick Harel-Bellan
anti-CD3 moAb
anti-Tac Antibodies
Asialo GM1
Augusto C. Ochoa
Author_Eva Lotzova
autologous
Autologous Tumor
Autologous Tumor Cells
Azzam Al Maghazachi
B. Altrock
Bm Graft
C. A. Savary
Carlo Riccardi
Caryn A. Giffen
Category=PSF
cellular immunotherapy
Charles M. Balch
D. V. Cramer
Donald E. Kern
Douglas K. Ferris
E. W. Ades
effector
eq_bestseller
eq_isMigrated=1
eq_isMigrated=2
eq_nobargain
eq_non-fiction
eq_science
F. Herrmann
Fred Ramsdell
Fritz H. Bach
G. P. Sarna
G. S. Long
Gloria Koo
Graziella Migliorati
H. Sabio
H. Shau
il-2
IL-2 Activate Natural Killer Cell
IL-2 Injection
IL-2 Treatment
immune modulation in oncology
J. C. Hiserodt
J. Kolitz
Jan Bubenik
Jay P. Klarnet
Jay P. Siegel
John C. Hiserodt
K562 Targets
Keisuke Sakai
Kiyotaka Okuno
Kyogo Itoh
LAK
LAK Activity
LAK Cell
LAK Cell Activity
LAK Precursor
lymphokine-activated killer cells
lytic
Lytic Activity
M. R. M. van den Brink
Marcel R. M. van den Brink
Martin A. Cheever
Mary F. Lipscomb
Mature NK Cell
N. L. Vujanovic
natural killer cell therapy
NK Activity
NK Cell
Normal Bm Cell
P. J. Voogt
Paul M. Sondel
PBL
Peter M. Anderson
Philip D. Greenberg
precursor
R. Mertelsmann
Raoul R. Salup
receptor
Richard P. Kitson
Robert H. Wiltrout
Robert Tompkins
Roderich E. Schwarz
Ronald B. Herberman
Ronald H. Goldfarb
Ronald L. Hornung
S. H. Golub
S. Nasr
Sidney Golub
Stuart W. Evans
Suyu Shu
Suzanne K. Beckner
Takaaki Chou
Teresa Alvarellos
Theresa L. Whiteside
Til Culture
tumor
Tumor Bearing Host
tumor-infiltrating lymphocytes
Vinay Kumar
W. H. Chambers
Warren J. Leonard
William L. Farrar
Y. Ibayashi
Y. Tokuda
Product details
- ISBN 9781315894690
- Weight: 870g
- Dimensions: 178 x 254mm
- Publication Date: 13 Dec 2017
- Publisher: Taylor & Francis Ltd
- Publication City/Country: GB
- Product Form: Hardback
Secure
checkout
Fast Shipping
Easy returns
This is the first-and only-publication available which provides the most recent information in this particular field of biomedicine. Interleukin-2 (IL-2) and IL-2 activated killer cells have been shown to have a potential in the treatment of a variety of human malignant diseases. This work comprehensively summarizes basic aspects of IL-2 as well as its clinical application, therefore making all these aspects easily accessible to the readers. Because of the clinical significance of this molecule in the treatment of cancer, the basic and clinical investigations in the IL-2 field are rapidly expanding, together with the interest of the scientific and medical community. This book is an excellent educational and teaching tool for scientists, clinicians, and students. Those who already have expertise in research in the IL-2 area will find this reference indispensible.
